NewsSource: EClinCloud

EClinCloud Product Overview | RM · Resource Management System

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image



EClinCloud RM (Resource Management) is an enterprise-grade resource management system that primarily provides contract management, staff management, and revenue and cost management for CROs, SMOs, pharmaceutical companies, and other organizations. Through the EClinCloud RM system, teams can break down contract tasks to achieve granular project management and precise human-resource allocation while controlling project risks.


RM

One-Stop Product + Service Solution





1

What Does EClinCloud Offer?

1

RM Resource Management System

2

System training and configuration services

3

Project task structure management system

4

Clinical trial team human-resource planning system




2

EClinCloud RM System Features


1

Systematically quantify human-resource input and output to formulate scientific human-resource and management plans

2

Can improve the accuracy and soundness of contract breakdown and accelerate project progress

3

Provide transparency into staff input and output for clear labor-cost accounting

4

Can evaluate corporate operations and management performance across multiple dimensions, helping enterprises create greater client value




3

Why Choose EClinCloud RM?

Article image

EClinCloud RM can provide enterprises with a scientific basis for evaluating employee performance

Can effectively reflect human-resource status across departments, supporting sound decision-making

Includes powerful BI data reports that can be customized for relevant business data based on current operations

EClinCloud RM interconnects with the CTMS system to synchronize operational tasks




About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interoperable cloud platform for clinical trials (including technology products and solutions such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within them such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) alongside clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system and ophthalmology). Combining frontier technology with life data, EClinCloud builds a globally leading, "patient-centric" SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate drug and medical device market launches, and benefit countless patients.







Article image

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.